BI-882370

Target: This ligand targets BRAF kinase, including the V600E mutant form in biochemical or cellular target-engagement studies.

Mechanism of Action: Used as the target-protein recognition element, this ligand provides the binding interface for BRAF kinase, including the V600E mutant form. In PROTAC design, a derivatizable position on the ligand can be connected through an optimized linker to an E3 ligase ligand, such as a CRBN, VHL, or IAP recruiter, while preserving productive target engagement. The resulting bifunctional molecule brings BRAF kinase into proximity with the recruited E3 ligase, enabling ternary-complex formation. If the complex has favorable geometry and residence time, target lysine ubiquitination is promoted, leading to proteasome-dependent degradation in experimental systems.

• PROTAC-Mediated Target Degradation: BI-882370 can be used as a ligand component in PROTAC constructs to recruit an E3 ligase and drive ubiquitination-dependent degradation of a chosen target protein. This application supports systematic testing of ternary complex formation and degradation potency across target variants, enabling mechanistic mapping of degradation efficiency and selectivity.

• E3 Ligase Recruitment Optimization: BI-882370 may be paired with different E3 ligase-recruiting modules to evaluate how ligase identity and linker context influence target ubiquitination. Researchers can use it to compare degradation kinetics, assess dependence on ubiquitin-proteasome activity, and identify configurations that maximize productive ternary complex engagement.

• Structure-Guided PROTAC Design: BI-882370 can serve as a starting ligand for structure-guided PROTAC optimization, including linker length, attachment position, and conformational constraints. By iteratively modifying PROTAC architecture, investigators can correlate binding geometry with degradation outcomes, improving understanding of how spatial proximity governs ubiquitin transfer.

• Cellular Mechanism and Selectivity Studies: BI-882370-containing PROTACs can be applied to interrogate degradation mechanisms in cellular models, including verifying proteasome dependence and distinguishing degradation from simple occupancy. This direction supports profiling of on-target versus off-target effects, using orthogonal assays such as time-resolved protein turnover measurements and proteome-level validation.

BI-882370 is a RAF-pathway kinase ligand scaffold that can support RAF-directed degrader design. Linker-vector selection should prioritize peripheral regions that do not disturb kinase engagement.

Structure: BI-882370 is a RAF-pathway kinase ligand scaffold containing a substituted heteroaryl core, halogenated aryl elements, amide-type functionality, and multiple heteroatoms. The structure provides a rigid aromatic recognition framework with polar groups that may contribute to kinase binding and physicochemical balance.

Reactivity: BI-882370-derived PROTAC design should preserve the central kinase-binding heteroaryl and amide recognition features. Linker installation is most appropriately explored from a solvent-exposed aryl or side-chain vector in a designed analog rather than by nonspecific modification of the parent scaffold. Alkyl, PEG, amide, carbamate, or ether-containing linkers may be paired with CRBN, VHL, or IAP ligands after confirming binding retention and selecting an exit vector that does not compromise RAF-family target engagement.